Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 8,421 | 6,816 | 6,791 | 6,009 | 6,989 |
| Operating Income | -8,421 | -6,816 | -6,791 | -6,009 | -6,989 |
| Other Income | -1 | 17 | 87 | 323 | 14 |
| Pre-tax Income | -8,422 | -6,799 | -6,704 | -5,686 | -6,975 |
| Net Income Continuous | -8,422 | -6,799 | -6,704 | -5,686 | -6,975 |
| Net Income | $-8,422 | $-6,799 | $-6,704 | $-5,686 | $-6,975 |
| EPS Basic Total Ops | -1.86 | -1.69 | -1.40 | -1.20 | -1.60 |
| EPS Basic Continuous Ops | -1.86 | -1.48 | -1.48 | -1.26 | -1.67 |
| EPS Diluted Total Ops | -1.86 | -1.69 | -1.40 | -1.20 | -1.60 |
| EPS Diluted Continuous Ops | -1.86 | -1.48 | -1.48 | -1.26 | -1.67 |
| EBITDA(a) | $-8,383 | $-6,748 | $-6,680 | $-5,891 | $-6,925 |